Q2 EPS Estimates for Voyager Therapeutics Lifted by Wedbush
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Research analysts at Wedbush raised their Q2 2025 EPS estimates for shares of Voyager Therapeutics in a research report issued to clients and investors on Tuesday, May 6th. Wedbush analyst Y. Zhong now expects that the company will earn ($0.31) per share for the quarter, up from […]
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Free Report) – Research analysts at Wedbush raised their Q2 2025 EPS estimates for shares of Voyager Therapeutics in a research report issued to clients and investors on Tuesday, May 6th. Wedbush analyst Y. Zhong now expects that the company will earn ($0.31) per share for the quarter, up from […]
